Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”

Peer Review reports

Original Submission
6 May 2019	Submitted	Original manuscript
20 May 2019	Reviewed	Reviewer Report - Shaun Treweek
23 May 2019	Author responded	Author comments - Jan Olof Gustav Karlsson
Resubmission - Version 2
23 May 2019	Submitted	Manuscript version 2
Publishing
27 May 2019	Editorially accepted
24 Jun 2019	Article published	10.1186/s13063-019-3476-3

Back to article page